683210-70-0

Basic information

• Product Name: (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester
• Synonyms: (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester
• CAS NO: 683210-70-0
• Molecular Weight: 439.486
• Mol File: 683210-70-0.mol

Chemical Properties

• CAS DataBase Reference: (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester(683210-70-0)
• EPA Substance Registry System: (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid methyl ester(683210-70-0)

Safety Data

• Hazardous Substances Data: 683210-70-0(Hazardous Substances Data)

Upstream product

• 683210-66-4 (1S,2R,4'R,5'S)-(benzyloxybenzenesulfonylamino)-[5'-(1-hydroxy-2-methanesulfonyloxyethyl)-2',2'-dimethyl[1,3]dioxolan-4'-yl]acetic acid methyl ester 
• 683210-61-9 (1,2R,4'R,5'S)-(4-benzyloxybenzenesulfonylamino)-[5'-(1,2-dihydroxyethyl)-2',2-dimethyl[1,3]-dioxolan-4'-yl]acetic acid methyl ester 
• 87001-32-9 p-benzyloxybenzenesulfonyl chloride 
• 3355-28-0 1-Bromo-2-butyne 

Downstream Products

• 683210-73-3 (3aR,4R,7R,7aR)-5-(4'-but-2'-ynyloxybenzenesulfonyl)-7-hydroxy-2,2-dimethylhexahydro[1,3]dioxolo[4,5-c]-4-carboxylic acid hydroxy amide 

Relevant articles and documents

Azasugar-Based MMP/ADAM Inhibitors as Antipsoriatic Agents

As a part of synthetic studies on MMP (matrix metalloproteinase)/ADAM (a disintegrin and metalloproteinase) inhibitors, we have preliminarily communicated that azasugar-based compound 1a exhibited a potential inhibitory activity on some metalloprotease-ca

Synthesis and biological activity of selective azasugar-based TACE inhibitors

A series of azasugar-based hydroxamic acid derivatives bearing 2R,3R,4R,5R-configuration is described. Compound 4c with 4,5-O-acetonide group showed excellent in vitro potency against TACE, with high selectivity over MMP-1 and moderate selectivity over MM